CPR Stock Analysis: Davide Campari-Milano | MI
Beverages - Wineries & Distilleries | MI, Italy | Market Cap: 6.821m EUR | 12M Return: -8.3% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 35.3M
Rev. Trend: 95.0%
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Davide Campari-Milano N.V. (CPR) is a global beverage company producing and distributing alcoholic and non-alcoholic drinks across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Founded in 1860 and headquartered in Sesto San Giovanni, Italy, the company operates as a subsidiary of Lagfin S.C.A.
Classified within the Consumer Staples sector under Distillers & Vintners, Campari runs a multi-category brand portfolio spanning aperitifs, vodka, whisky, rum, agave-based spirits, cognac, and champagne. Flagship labels include Campari, Aperol, Wild Turkey, Appleton Estate, Grand Marnier, Courvoisier, and SKYY Vodka, alongside numerous regional and specialty brands such as SKYY, Bulldog Gin, Averna, Frangelico, and Espolòn.
Its business model relies on a multi-brand strategy, with each label positioned for distinct consumer segments and distributed through international networks, giving the group exposure across both premium and mainstream price tiers in the global spirits market.
- Courvoisier cognac acquisition expands US premium spirits exposure
- Aperol Spritz demand sensitive to European summer weather volatility
- Deleveraging post-acquisition limits near-term capital returns
| Net Income: 242.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.31 > 1.0 |
| NWC/Revenue: 36.06% < 20% (prev 38.54%; Δ -2.48% < -1%) |
| CFO/TA 0.08 > 3% & CFO 687.6m > Net Income 242.2m |
| Net Debt (2.09b) to EBITDA (802.0m): 2.61 < 3 |
| Current Ratio: 2.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.20b) vs 12m ago 5.66% < -2% |
| Gross Margin: 58.50% > 18% (prev 57.39%; Δ 1.10% > 0.5%) |
| Asset Turnover: 54.36% > 50% (prev 51.88%; Δ 2.48% > 0%) |
| Interest Coverage Ratio: 3.24 > 6 (EBIT TTM 653.7m / Interest Expense TTM 201.7m) |
| A: 0.20 (Total Current Assets 2.96b - Total Current Liabilities 1.34b) / Total Assets 8.11b |
| B: 0.50 (Retained Earnings 4.08b / Total Assets 8.11b) |
| C: 0.08 (EBIT TTM 653.7m / Avg Total Assets 8.30b) |
| D: 0.91 (Book Value of Equity 3.86b / Total Liabilities 4.25b) |
| Altman-Z'' = 4.44 = AA |
| DSRI: 0.73 (Receivables 327.1m/439.3m, Revenue 4.51b/4.40b) |
| GMI: 0.98 (GM 57.39% / 58.50%) |
| AQI: 0.94 (AQ_t 0.45 / AQ_t-1 0.48) |
| SGI: 1.02 (Revenue 4.51b / 4.40b) |
| TATA: -0.05 (NI 242.2m - CFO 687.6m) / TA 8.11b) |
| Beneish M = -3.29 (Cap -4..+1) = AA |
As of July 23, 2026, the stock is trading at EUR 5.71 with a total of 6,220,127 shares traded. Over the past week, the price has changed by +2.59%, over one month by +3.97%, over three months by -9.86% and over the past year by -8.31%.
Current recommended Stop Loss: 5.50 (which is 3.7% or 1.7 ATR below the current price).
Davide Campari-Milano has no consensus analysts rating.
P/E Trailing = 19.6207
P/E Forward = 17.2414
P/S = 2.2355
P/B = 1.7658
P/EG = 1.7004
Revenue TTM = 4.51b EUR
EBIT TTM = 653.7m EUR
EBITDA TTM = 802.0m EUR
Long Term Debt = 2.22b EUR (from longTermDebt, last quarter)
Short Term Debt = 272.2m EUR (from shortLongTermDebt, last quarter)
Debt = 2.80b EUR (from shortLongTermDebtTotal, two quarters ago) + Leases 71.6m
Net Debt = 2.09b EUR (calculated: Debt 2.80b - CCE 703.3m)
Enterprise Value = 8.91b EUR (6.82b + Debt 2.80b - CCE 703.3m)
Interest Coverage Ratio = 3.24 (Ebit TTM 653.7m / Interest Expense TTM 201.7m)
EV/FCF = 22.96x (Enterprise Value 8.91b / FCF TTM 388.3m)
FCF Yield = 4.36% (FCF TTM 388.3m / Enterprise Value 8.91b)
FCF Margin = 8.61% (FCF TTM 388.3m / Revenue TTM 4.51b)
Net Margin = 5.37% (Net Income TTM 242.2m / Revenue TTM 4.51b)
Gross Margin = 58.50% ((Revenue TTM 4.51b - Cost of Revenue TTM 1.87b) / Revenue TTM)
Gross Margin QoQ = 57.62% (prev 61.12%)
Tobins Q-Ratio = 1.10 (Enterprise Value 8.91b / Total Assets 8.11b)
Interest Expense / Debt = 7.21% (Interest Expense 201.7m / Debt 2.80b)
Taxrate = 27.66% (127.3m / 460.3m)
NOPAT = 472.9m (EBIT 653.7m * (1 - 27.66%))
Current Ratio = 2.22 (Total Current Assets 2.96b / Total Current Liabilities 1.34b)
Debt / Equity = 0.72 (Debt 2.80b / totalStockholderEquity, last quarter 3.86b)
Debt / EBITDA = 2.61 (Net Debt 2.09b / EBITDA 802.0m)
Debt / FCF = 5.39 (Net Debt 2.09b / FCF TTM 388.3m)
Total Stockholder Equity = 3.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.92% (Net Income 242.2m / Total Assets 8.11b)
RoE = 6.36% (Net Income TTM 242.2m / Total Stockholder Equity 3.81b)
RoCE = 10.85% (EBIT 653.7m / Capital Employed (Equity 3.81b + L.T.Debt 2.22b))
RoIC = 7.22% (NOPAT 472.9m / Invested Capital 6.55b)
WACC = 5.39% (E(6.82b)/V(9.62b) * Re(5.46%) + D(2.80b)/V(9.62b) * Rd(7.21%) * (1-Tc(0.28)))
Discount Rate = 5.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.41 | Cagr: 5.03%
[DCF] Terminal Value 77.97% ; FCFF base≈317.1m ; Y1≈363.5m ; Y5≈535.0m
[DCF] Fair Price = 4.97 (EV 8.05b - Net Debt 2.09b = Equity 5.96b / Shares 1.20b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 95.01 | Revenue CAGR: 4.24% | SUE: N/A | # QB: 0
EPS current Quarter (2025-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2025-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2025-12-31): EPS=0.30 | Chg30d=+0.43% | Revisions=-35% | GrowthEPS=-3.0% | GrowthRev=-0.6%
EPS next Year (2026-12-31): EPS=0.31 | Chg30d=-0.71% | Revisions=-7% | GrowthEPS=-3.2% | GrowthRev=+0.2%
[Analyst] Revisions Ratio: -25% (up=9, down=16)